PROSENSA HOLDING N.V.

Profile

Company Names

PROSENSA HOLDING N.V.

Addresses

J.H. OORTWEG 21, LEIDEN, P7 2333 CH

Phone Numbers

31 0 713322100

 

Entity Type:

OTHER

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NETHERLANDS

Total Amount Raised:

$50,488,095.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2014-11-26 
$50,488,095.00 
$50,488,095.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GILES 
 
CAMPION 
EXECUTIVE OFFICER
PROSENSA HOLDING N.V.   |  SILENCE THERAPEUTICS PLC
LUC 
 
DOCHEZ 
EXECUTIVE OFFICER
PROSENSA HOLDING N.V.   |  ERYTECH PHARMA S.A.   |  QURALIS CORP   |  SUMMATION BIO, INC.   |  VOLASTRA THERAPEUTICS, INC.
DAAN 
 
ELLENS 
DIRECTOR
PROSENSA HOLDING N.V.
GEORGES 
 
GEMAYEL 
DIRECTOR
PROSENSA HOLDING N.V.
PETER 
 
GOODFELLOW 
DIRECTOR
PROSENSA HOLDING N.V.   |  GENSIGHT BIOLOGICS S.A.
ANNALISA 
 
JENKINS 
DIRECTOR
PROSENSA HOLDING N.V.   |  BIOTHERA HOLDING CORP.   |  DIMENSION THERAPEUTICS, INC.   |  ARDELYX, INC.   |  ONCOSEC MEDICAL INC   |  VIUM, INC.   |  AGEX THERAPEUTICS, INC.   |  COCOON BIOTECH INC.   |  SKYE BIOSCIENCE, INC.   |  ETIRARX, INC.
MARTIJN 
 
KLEIJWEGT 
DIRECTOR
PASTEURIA BIOSCIENCE, INC.   |  PROSENSA HOLDING N.V.   |  LIFE SCIENCES PARTNERS V C.V.   |  KIADIS PHARMA N.V.   |  EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.
BERNDT 
 
MODIG 
EXECUTIVE OFFICER
PROSENSA HOLDING N.V.   |  KIADIS PHARMA N.V.
DAVID 
 
MOTT 
DIRECTOR
3-V BIOSCIENCES, INC.   |  TESARO, INC.   |  ARDELYX, INC.   |  ZYNGENIA, INC.   |  OMTHERA PHARMACEUTICALS, INC.   |  MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  EDIMER PHARMACEUTICALS, INC.   |  PROSENSA HOLDING N.V.   |  ADAPTIMMUNE LTD   |  MERSANA THERAPEUTICS, INC.   |  XTUIT PHARMACEUTICALS, INC.   |  IMARA INC.   |  COMPLEXA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
HANS 
 
SCHIKAN 
EXECUTIVE OFFICER
PROSENSA HOLDING N.V.
MICHAEL 
 
WYZGA 
DIRECTOR
ONCOMED PHARMACEUTICALS INC   |  PROSENSA HOLDING N.V.   |  AURA BIOSCIENCES, INC.   |  X4 PHARMACEUTICALS, INC.   |  MEREO BIOPHARMA GROUP PLC   |  TVARDI THERAPEUTICS, INC.   |  X4 PHARMACEUTICALS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-12-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2014-11-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#